SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-23-025648
Filing Date
2023-02-06
Accepted
2023-02-06 16:32:01
Documents
1
Group Members
NEW LEAF BPO ASSOCIATES I, L.P.NEW LEAF VENTURE MANAGEMENT III, L.L.C.RONALD M. HUNTVIJAY K. LATHI

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d441785dsc13ga.htm SC 13G/A 96625
  Complete submission text file 0001193125-23-025648.txt   98439
Mailing Address CHEMIN DES MINES 9 GENEVA V8 CH-1202
Business Address CHEMIN DES MINES 9 GENEVA V8 CH-1202 01141228841555
Addex Therapeutics Ltd. (Subject) CIK: 0001574232 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91805 | Film No.: 23591125
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEW LEAF VENTURE PARTNERS 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036
Business Address C/O NEW LEAF VENTURE PARTNERS 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036 646-871-6400
New Leaf Biopharma Opportunities I, L.P. (Filed by) CIK: 0001625696 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A